2015
DOI: 10.1016/j.neurobiolaging.2015.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
54
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 104 publications
(60 citation statements)
references
References 60 publications
5
54
0
1
Order By: Relevance
“…Hesperidin at the dose of 100 mg/kg and silibinin (100 and 200 mg/kg) significantly prevented the AChE elevation in the hippocampus. Our results are in accordance with the earlier studies with regards to the AChE inhibitor activity of hesperidin and silibinin [32,56,61,62]. Inhibition of AlCl 3 -evoked hippocampal AChE level by hesperidin and silibinin might be attributed to the improvement in the memory function.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Hesperidin at the dose of 100 mg/kg and silibinin (100 and 200 mg/kg) significantly prevented the AChE elevation in the hippocampus. Our results are in accordance with the earlier studies with regards to the AChE inhibitor activity of hesperidin and silibinin [32,56,61,62]. Inhibition of AlCl 3 -evoked hippocampal AChE level by hesperidin and silibinin might be attributed to the improvement in the memory function.…”
Section: Discussionsupporting
confidence: 93%
“…Our study is corroborated by a recent study which showed that AlCl 3 impaired the long-term memory through modulation of cAMP-PKA-CREB signaling and BDNF level in the hippocampus [54]. Previous experimental reports suggested that hesperidin and silibinin exerted neuroprotection through elevation of the BDNF level [55,56]. Our present study showed a prominent increase in hippocampal BDNF level in the groups treated with hesperidin and silibinin.…”
Section: Discussionsupporting
confidence: 91%
“…Silybin, the major active molecule of silymarin, is a very potent antioxidant compound capable of scavenging free radicals and ROS, and has been shown to exert neuroprotective (2830), hepatoprotective (31,32) and anti-carcinogenic effects (3335). It is now being used as a traditional medicine for the treatment of various liver disorders in China.…”
Section: Discussionmentioning
confidence: 99%
“…So MWM has been applied in the novel drug candidate discoveries widely. For example, MWM was used to evaluate the effect of silibinin on AD, and the result showed that silibinin could improve the performance of APP/PS1 transgenic mice after dosing with silibinin [68]. And the mechanism revealed that silibinin might act as a dual-target drug for the treatment of AD by inhibiting amyloid β peptide aggregation and the acetylcholinesterase activity [68].…”
Section: Mwm In Novel Drug Candidate Discoveriesmentioning
confidence: 99%
“…For example, MWM was used to evaluate the effect of silibinin on AD, and the result showed that silibinin could improve the performance of APP/PS1 transgenic mice after dosing with silibinin [68]. And the mechanism revealed that silibinin might act as a dual-target drug for the treatment of AD by inhibiting amyloid β peptide aggregation and the acetylcholinesterase activity [68]. For another example, lycopene was found to abrogate neuroinflammatory cascade in intra cerebroventricular injection of β-amyloid1-42-induced learning and memory impairment mice using MWM [69].…”
Section: Mwm In Novel Drug Candidate Discoveriesmentioning
confidence: 99%